Rare heterozygous GDF6 variants in patients with renal anomalies.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
12 2020
Historique:
received: 20 03 2020
accepted: 15 06 2020
revised: 05 06 2020
pubmed: 2 8 2020
medline: 3 6 2021
entrez: 2 8 2020
Statut: ppublish

Résumé

Although over 50 genes are known to cause renal malformation if mutated, the underlying genetic basis, most easily identified in syndromic cases, remains unsolved in most patients. In search of novel causative genes, whole-exome sequencing in a patient with renal, i.e., crossed fused renal ectopia, and extrarenal, i.e., skeletal, eye, and ear, malformations yielded a rare heterozygous variant in the GDF6 gene encoding growth differentiation factor 6, a member of the BMP family of ligands. Previously, GDF6 variants were reported to cause pleiotropic defects including skeletal, e.g., vertebral, carpal, tarsal fusions, and ocular, e.g., microphthalmia and coloboma, phenotypes. To assess the role of GDF6 in the pathogenesis of renal malformation, we performed targeted sequencing in 193 further patients identifying rare GDF6 variants in two cases with kidney hypodysplasia and extrarenal manifestations. During development, gdf6 was expressed in the pronephric tubule of Xenopus laevis, and Gdf6 expression was observed in the ureteric tree of the murine kidney by RNA in situ hybridization. CRISPR/Cas9-derived knockout of Gdf6 attenuated migration of murine IMCD3 cells, an effect rescued by expression of wild-type but not mutant GDF6, indicating affected variant function regarding a fundamental developmental process. Knockdown of gdf6 in Xenopus laevis resulted in impaired pronephros development. Altogether, we identified rare heterozygous GDF6 variants in 1.6% of all renal anomaly patients and 5.4% of renal anomaly patients additionally manifesting skeletal, ocular, or auricular abnormalities, adding renal hypodysplasia and fusion to the phenotype spectrum of GDF6 variant carriers and suggesting an involvement of GDF6 in nephrogenesis.

Identifiants

pubmed: 32737436
doi: 10.1038/s41431-020-0678-9
pii: 10.1038/s41431-020-0678-9
pmc: PMC7784874
doi:

Substances chimiques

GDF6 protein, human 0
Growth Differentiation Factor 6 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1681-1693

Subventions

Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : KO5614/2-1
Pays : International
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : LI1817/2-1
Pays : International
Organisme : Medizinischen Hochschule Hannover (Hannover Medical School)
ID : Hochschulinterne Leistungsförderung (HiLF)
Pays : International

Références

Queisser-Luft A, Stolz G, Wiesel A, Schlaefer K, Spranger J. Malformations in newborn: results based on 30,940 infants and fetuses from the Mainz congenital birth defect monitoring system (1990–1998). Arch Gynecol Obstet. 2002;266:163–7.
pubmed: 12197558 doi: 10.1007/s00404-001-0265-4
Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012;27:363–73.
pubmed: 21713524 doi: 10.1007/s00467-011-1939-1
Limwongse C. Syndromes and malformations of the urinary tract. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. Berlin, Heidelberg, Germany: Springer; 2009. p. 121–56.
doi: 10.1007/978-3-540-76341-3_6
Stoll C, Dott B, Alembik Y, Roth MP. Associated nonurinary congenital anomalies among infants with congenital anomalies of kidney and urinary tract (CAKUT). Eur J Med Genet. 2014;57:322–8.
pubmed: 24821302 doi: 10.1016/j.ejmg.2014.04.014
Sanna-Cherchi S, Westland R, Ghiggeri GM, Gharavi AG. Genetic basis of human congenital anomalies of the kidney and urinary tract. J Clin Invest. 2018;128:4–15.
pubmed: 29293093 pmcid: 5749511 doi: 10.1172/JCI95300
Kosfeld A, Martens H, Hennies I, Haffner D, Weber RG. Kongenitale Anomalien der Nieren und ableitenden Harnwege (CAKUT). Med Genet. 2018;30:448–60.
van der Ven AT, Vivante A, Hildebrandt F. Novel insights into the pathogenesis of monogenic congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. 2018;29:36–50.
pubmed: 29079659 doi: 10.1681/ASN.2017050561
Heidet L, Moriniere V, Henry C, De Tomasi L, Reilly ML, Humbert C, et al. Targeted exome sequencing identifies PBX1 as involved in monogenic congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. 2017;28:2901–14.
pubmed: 28566479 pmcid: 5619971 doi: 10.1681/ASN.2017010043
van der Ven AT, Connaughton DM, Ityel H, Mann N, Nakayama M, Chen J, et al. Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract. J Am Soc Nephrol. 2018;29:2348–61.
pubmed: 30143558 pmcid: 6115658 doi: 10.1681/ASN.2017121265
Nigam A, Knoers N, Renkema KY. Impact of next generation sequencing on our understanding of CAKUT. Semin Cell Dev Biol. 2019;91:104–10.
pubmed: 30172048 doi: 10.1016/j.semcdb.2018.08.013
Vivante A, Kleppa MJ, Schulz J, Kohl S, Sharma A, Chen J, et al. Mutations in TBX18 cause dominant urinary tract malformations via transcriptional dysregulation of ureter development. Am J Hum Genet. 2015;97:291–301.
pubmed: 26235987 pmcid: 4862256 doi: 10.1016/j.ajhg.2015.07.001
Brophy PD, Rasmussen M, Parida M, Bonde G, Darbro BW, Hong X, et al. A gene implicated in activation of retinoic acid receptor targets is a novel renal agenesis gene in humans. Genetics. 2017;207:215–28.
pubmed: 28739660 pmcid: 5586373 doi: 10.1534/genetics.117.1125
Humbert C, Silbermann F, Morar B, Parisot M, Zarhrate M, Masson C, et al. Integrin alpha 8 recessive mutations are responsible for bilateral renal agenesis in humans. Am J Hum Genet. 2014;94:288–94.
pubmed: 24439109 pmcid: 3928807 doi: 10.1016/j.ajhg.2013.12.017
De Tomasi L, David P, Humbert C, Silbermann F, Arrondel C, Tores F, et al. Mutations in GREB1L cause bilateral kidney agenesis in humans and mice. Am J Hum Genet. 2017;101:803–14.
pubmed: 29100091 pmcid: 5673669 doi: 10.1016/j.ajhg.2017.09.026
Kosfeld A, Kreuzer M, Daniel C, Brand F, Schafer AK, Chadt A, et al. Whole-exome sequencing identifies mutations of TBC1D1 encoding a Rab-GTPase-activating protein in patients with congenital anomalies of the kidneys and urinary tract (CAKUT). Hum Genet. 2016;135:69–87.
pubmed: 26572137 doi: 10.1007/s00439-015-1610-1
Kosfeld A, Brand F, Weiss AC, Kreuzer M, Goerk M, Martens H, et al. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations. Hum Mol Genet. 2017;26:1716–31.
pubmed: 28334964 doi: 10.1093/hmg/ddx086
Tassabehji M, Fang ZM, Hilton EN, McGaughran J, Zhao Z, Bock CEd, et al. Mutations in GDF6 are associated with vertebral segmentation defects in Klippel–Feil syndrome. Hum Mutat. 2008;29:1017–27.
pubmed: 18425797 doi: 10.1002/humu.20741
Asai-Coakwell M, French CR, Ye M, Garcha K, Bigot K, Perera AG, et al. Incomplete penetrance and phenotypic variability characterize Gdf6-attributable oculo-skeletal phenotypes. Hum Mol Genet. 2009;18:1110–21.
pubmed: 19129173 doi: 10.1093/hmg/ddp008
Asai-Coakwell M, March L, Dai XH, Duval M, Lopez I, French CR, et al. Contribution of growth differentiation factor 6-dependent cell survival to early-onset retinal dystrophies. Hum Mol Genet. 2013;22:1432–42.
pubmed: 23307924 doi: 10.1093/hmg/dds560
den Hollander AI, Biyanwila J, Kovach P, Bardakjian T, Traboulsi EI, Ragge NK, et al. Genetic defects of GDF6 in the zebrafish out of sight mutant and in human eye developmental anomalies. BMC Genet. 2010;11:102.
doi: 10.1186/1471-2156-11-102
Gonzalez-Rodriguez J, Pelcastre EL, Tovilla-Canales JL, Garcia-Ortiz JE, Amato-Almanza M, Villanueva-Mendoza C, et al. Mutational screening of CHX10, GDF6, OTX2, RAX and SOX2 genes in 50 unrelated microphthalmia-anophthalmia-coloboma (MAC) spectrum cases. Br J Ophthalmol. 2010;94:1100–4.
pubmed: 20494911 doi: 10.1136/bjo.2009.173500
Slavotinek AM, Garcia ST, Chandratillake G, Bardakjian T, Ullah E, Wu D, et al. Exome sequencing in 32 patients with anophthalmia/microphthalmia and developmental eye defects. Clin Genet. 2015;88:468–73.
pubmed: 25457163 pmcid: 4452457 doi: 10.1111/cge.12543
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
pubmed: 25741868 pmcid: 4544753 doi: 10.1038/gim.2015.30
Markunas CA, Soldano K, Dunlap K, Cope H, Asiimwe E, Stajich J, et al. Stratified whole genome linkage analysis of Chiari type I malformation implicates known Klippel-Feil syndrome genes as putative disease candidates. PLoS ONE. 2013;8:e61521.
pubmed: 23620759 pmcid: 3631233 doi: 10.1371/journal.pone.0061521
Drage Berentsen R, Haukanes BI, Juliusson PB, Rosendahl K, Houge G. A novel GDF6 mutation in a family with multiple synostoses syndrome without hearing loss. Mol Syndromol. 2019;9:228–34.
pubmed: 30733656 doi: 10.1159/000492418
Terhal PA, Verbeek NE, Knoers N, Nievelstein R, van den Ouweland A, Sakkers RJ, et al. Further delineation of the GDF6 related multiple synostoses syndrome. Am J Med Genet A. 2018;176:225–9.
pubmed: 29130651 doi: 10.1002/ajmg.a.38503
Wang J, Yu T, Wang Z, Ohte S, Yao R-E, Zheng Z, et al. A new subtype of multiple synostoses syndrome is caused by a mutation in GDF6 that decreases its sensitivity to noggin and enhances its potency as a BMP signal. J Bone Min Res. 2016;31:882–9.
doi: 10.1002/jbmr.2761
Chassaing N, Causse A, Vigouroux A, Delahaye A, Alessandri J-L, Boespflug-Tanguy O, et al. Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia. Clin Genet. 2014;86:326–34.
pubmed: 24033328 doi: 10.1111/cge.12275
Huang X, Xiao X, Jia X, Li S, Li M, Guo X, et al. Mutation analysis of the genes associated with anterior segment dysgenesis, microcornea and microphthalmia in 257 patients with glaucoma. Int J Mol Med. 2015;36:1111–7.
pubmed: 26310487 doi: 10.3892/ijmm.2015.2325
Nixon TRW, Richards A, Towns LK, Fuller G, Abbs S, Alexander P, et al. Bone morphogenetic protein 4 (BMP4) loss-of-function variant associated with autosomal dominant Stickler syndrome and renal dysplasia. Eur J Hum Genet. 2019;27:369–77.
pubmed: 30568244 doi: 10.1038/s41431-018-0316-y
De Caestecker M. The transforming growth factor-b: superfamily of receptors. Cytokine Growth Factor Rev. 2004;15:1–11.
pubmed: 14746809 doi: 10.1016/j.cytogfr.2003.10.004
Chang C, Hemmati-Brivanlou A. Xenopus GDF6, a new antagonist of noggin and a partner of BMPs. Development. 1999;126:3347–57.
pubmed: 10393114 doi: 10.1242/dev.126.15.3347
Harrison CA, Al-Musawi SL, Walton KL. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands. Growth Factors. 2011;29:174–86.
pubmed: 21864080 doi: 10.3109/08977194.2011.608666
Neugebauer JM, Kwon S, Kim HS, Donley N, Tilak A, Sopory S, et al. The prodomain of BMP4 is necessary and sufficient to generate stable BMP4/7 heterodimers with enhanced bioactivity in vivo. Proc Natl Acad Sci USA. 2015;112:E2307–16.
pubmed: 25902523 doi: 10.1073/pnas.1501449112 pmcid: 4426409
Cain JE, Hartwig S, Bertram JF, Rosenblum ND. Bone morphogenetic protein signaling in the developing kidney: present and future. Differentiation. 2008;76:831–42.
pubmed: 18331343 doi: 10.1111/j.1432-0436.2008.00265.x
Nishinakamura R, Sakaguchi M. BMP signaling and its modifiers in kidney development. Pediatr Nephrol. 2014;29:681–6.
pubmed: 24217785 doi: 10.1007/s00467-013-2671-9
Wang RN, Green J, Wang Z, Deng Y, Qiao M, Peabody M, et al. Bone morphogenetic protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1:87–105.
pubmed: 25401122 pmcid: 4232216 doi: 10.1016/j.gendis.2014.07.005
Mamo TM, Wittern AB, Kleppa M-J, Bohnenpoll T, Weiss A-C, Kispert A. BMP4 uses several different effector pathways to regulate proliferation and differentiation in the epithelial and mesenchymal tissue compartments of the developing mouse ureter. Hum Mol Genet. 2017;26:3553–63.
pubmed: 28655168 doi: 10.1093/hmg/ddx242
Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest. 2000;105:863–73.
pubmed: 10749566 pmcid: 377476 doi: 10.1172/JCI8256
Dudley AT, Lyons KM, Robertson EJ. A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. 1995;9:2795–807.
pubmed: 7590254 doi: 10.1101/gad.9.22.2795
Esquela AF, Lee SJ. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev Biol. 2003;257:356–70.
pubmed: 12729564 doi: 10.1016/S0012-1606(03)00100-3
Settle SH, Rountree RB, Sinha A, Thacker A, Higgins K, Kingsley DM. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev Biol. 2003;254:116–30.
pubmed: 12606286 doi: 10.1016/S0012-1606(02)00022-2
Mikic B, Rossmeier K, Bierwert L. Identification of a tendon phenotype in GDF6 deficient mice. Anat Rec. 2009;292:396–400.
doi: 10.1002/ar.20852
Indjeian VB, Kingman GA, Jones FC, Guenther CA, Grimwood J, Schmutz J, et al. Evolving new skeletal traits by cis-regulatory changes in bone morphogenetic proteins. Cell. 2016;164:45–56.
pubmed: 26774823 pmcid: 4759241 doi: 10.1016/j.cell.2015.12.007
Asai-Coakwell M, French CR, Berry KM, Ye M, Koss R, Somerville M, et al. GDF6, a novel locus for a spectrum of ocular developmental anomalies. Am J Hum Genet. 2007;80:306–15.
pubmed: 17236135 doi: 10.1086/511280
Weber S, Taylor JC, Winyard P, Baker KF, Sullivan-Brown J, Schild R, et al. SIX2 and BMP4 mutations associate with anomalous kidney development. J Am Soc Nephrol. 2008;19:891–903.
pubmed: 18305125 pmcid: 2386720 doi: 10.1681/ASN.2006111282
Suzuki K, Adachi Y, Numata T, Nakada S, Yanagita M, Nakagata N, et al. Reduced BMP signaling results in hindlimb fusion with lethal pelvic/urogenital organ aplasia: a new mouse model of sirenomelia. PLoS ONE. 2012;7:e43453.
pubmed: 23028455 pmcid: 3444444 doi: 10.1371/journal.pone.0043453
Taghavi K, Kirkpatrick J, Mirjalili SA. The horseshoe kidney: Surgical anatomy and embryology. J Pediatr Urol. 2016;12:275–80.
pubmed: 27324557 doi: 10.1016/j.jpurol.2016.04.033

Auteurs

Helge Martens (H)

Department of Human Genetics, Hannover Medical School, 30625, Hannover, Germany.

Imke Hennies (I)

Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, 30625, Hannover, Germany.

Maike Getwan (M)

Department of Medicine, Renal Division, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, 79110, Freiburg, Germany.
Institute of Anatomy and Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, 8057, Zurich, Switzerland.

Anne Christians (A)

Department of Human Genetics, Hannover Medical School, 30625, Hannover, Germany.

Anna-Carina Weiss (AC)

Institute of Molecular Biology, Hannover Medical School, 30625, Hannover, Germany.

Frank Brand (F)

Department of Human Genetics, Hannover Medical School, 30625, Hannover, Germany.

Ann Christin Gjerstad (AC)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, 0424, Oslo, Norway.

Arne Christians (A)

Department of Neuropathology, Institute of Pathology, Hannover Medical School, 30625, Hannover, Germany.

Zoran Gucev (Z)

Medical Faculty Skopje, University Children's Hospital, 1000, Skopje, North Macedonia.

Robert Geffers (R)

Genome Analytics Research Group, Helmholtz Centre for Infection Research, 38124, Braunschweig, Germany.

Tomáš Seeman (T)

Department of Paediatrics and Transplantation Center, University Hospital Motol, Second Faculty of Medicine, Charles University, 150 06, Prague, Czech Republic.

Andreas Kispert (A)

Institute of Molecular Biology, Hannover Medical School, 30625, Hannover, Germany.

Velibor Tasic (V)

Medical Faculty Skopje, University Children's Hospital, 1000, Skopje, North Macedonia.

Anna Bjerre (A)

Division of Paediatric and Adolescent Medicine, Oslo University Hospital, 0424, Oslo, Norway.

Soeren S Lienkamp (SS)

Department of Medicine, Renal Division, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, 79110, Freiburg, Germany.
Institute of Anatomy and Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, 8057, Zurich, Switzerland.

Dieter Haffner (D)

Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, 30625, Hannover, Germany.

Ruthild G Weber (RG)

Department of Human Genetics, Hannover Medical School, 30625, Hannover, Germany. weber.ruthild@mh-hannover.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH